GlassScriptPhysician profile
Guido Albert Torres
NPI 1427108604
$39,969.14
in general payments reported to CMS, 2019-2025
36 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,226 · 2020: $9,535 · 2021: $28K · 2022: $667 · 2023: $612 · 2024: $231 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.22 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $36,581.45 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $627.16 | 2019-2023 | Liletta |
| Pfizer INC. | $401.77 | 2019-2023 | |
| Astellas Pharma US INC | $282.91 | 2023 | Veozah, Myrbetriq |
| Caldera Medical, INC | $252.51 | 2019 | |
| Mayne Pharma Commercial LLC | $184.69 | 2022-2023 | |
| Vertical Pharmaceuticals, LLC | $181.60 | 2019-2020 | |
| Daiichi Sankyo INC. | $156.81 | 2019-2024 | Injectafer |
| Exeltis, USA INC. | $114.21 | 2021-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $107.68 | 2019-2023 | |
| Hologic Sales and Service, LLC | $95.25 | 2019-2021 | |
| Therapeuticsmd, INC. | $84.50 | 2020-2022 | |
| Evofem Biosciences, INC. | $76.34 | 2022 | |
| Allergan, INC. | $74.41 | 2019-2020 | |
| Minerva Surgical, INC | $73.95 | 2022-2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $60.11 | 2019-2020 | |
| Sage Therapeutics, LLC | $56.26 | 2024 | |
| Momentis Surgical INC. | $56.00 | 2022 | |
| Merck Sharp & Dohme LLC | $43.83 | 2019-2023 | Gardasil 9 |
| Agile Therapeutics, INC. | $43.31 | 2022 | |
| Myovant Sciences INC. | $43.31 | 2021-2022 | |
| Coloplast Corp | $41.94 | 2019-2021 | |
| Axonics, INC. | $40.05 | 2021-2024 | Bulkamid, Axonics |
| Sumitomo Pharma America, INC. | $39.79 | 2023-2024 | Myfembree |
| Boston Scientific Corporation | $39.21 | 2019-2023 | Solyx Sis System |
| Ethicon US, LLC | $38.10 | 2019 | |
| Shield Therapeutics INC | $26.23 | 2024 | |
| Amgen INC. | $23.85 | 2019 | |
| Innovation Technologies INC | $23.45 | 2025 | Irrisept |
| Forte Bio-Pharma LLC | $18.12 | 2019 | |
| Mylan Pharmaceuticals INC. | $16.79 | 2021 | |
| Avion Pharmaceuticals | $14.24 | 2021 | |
| Conmed Corporation | $13.60 | 2021 | |
| Olympus America INC. | $12.83 | 2023 | |
| Lupin INC. | $12.42 | 2019 | |
| Organon LLC | $10.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guido Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.